Spots Global Cancer Trial Database for all authorized tki monotherapies in advanced rcc per fda label in advanced rcc
Every month we try and update this database with for all authorized tki monotherapies in advanced rcc per fda label in advanced rcc cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study Of Cabozantinib Treatment In Patients With Unresectable, Locally Advanced Or Metastatic Renal Cell Carcinoma Who Progressed After Previous Treatment With Checkpoint Inhibitors | NCT04353765 | Locally Advance... | Cabozantinib mo... All authorized ... | 18 Years - | Ipsen |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
